Neuromodulation Parameter Efficacy

Evaluating the Efficacy of Different Stimulation Paradigms in Neuromodulation

Status

Recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04933370

Enrollment

Registered

2021-06-21

Start date

2022-02-01

Completion date

2026-07-01

Last updated

2024-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

The objective of this study is to determine the efficacy of neuromodulation using various stimulation paradigms in the treatment of several disorders including chronic pain.

Detailed description

Different stimulation parameters will be tried in a blinded fashion to compare efficacy.

Interventions

OTHERStimulation parameters

Different device stimulation parameters

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Patients who are candidates for, and have been consented for, implantation of a neuromodulation device.

Exclusion criteria

* Non-English speaking

Design outcomes

Primary

Measure	Time frame	Description
Change in baseline pain measures	6 months	Pain outcomes measured using visual analogue scale

Secondary

Measure	Time frame	Description
Effect of stimulation on quality of life	6 months	As measured using EQ-5D-3L

Countries

Canada

Contacts

Primary ContactFady Girgis, MD

fmgirgis@ucalgary.ca4039446497

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026